Activated AMPK also boosts Nrf2/HO-1 signaling and suppresses mTOR pathways, promoting autophagy and mitochondrial biogenesis, which helps improve NASH (Figure 3) [61,62]. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatohepatitis.